GoodRx Holdings, Inc. (GDRX) Misses Q3 EPS by 14c; Guides Lower

GoodRx Holdings, Inc. (NASDAQ: GDRX) reported Q3 EPS of ($0.10), $0.14 worse than the analyst estimate of $0.04. Revenue for the quarter came in at $187.3 million versus the consensus estimate of $185.01 million.

GUIDANCE:

GoodRx Holdings, Inc. sees Q4 2022 revenue of $173-180 million, versus the consensus of $204.24 million.

For earnings history and earnings-related data on GoodRx Holdings, Inc. (GDRX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c